ALK and neoplasm: Here, we report that the combination of ceritinib with CGM097 promotes apoptosis in ALK mutant/TP53 wild-type neuroblastoma cell lines and results in complete tumor regression and markedly prolonged survival in neuroblastoma xenograft models.